Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software & TMT
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
08 feb 2023
Carlsquare weekly market letter: MAAGT replaces the FANG companies
Equity Research
Carlsquare
01 feb 2023
Carlsquare weekly market letter: Time to go fishing
Equity Research
Carlsquare
25 jan 2023
Carlsquare weekly market letter: Why doesn't the Fed stop their rate hikes to give the economy some much wanted breathing room?
Equity Research
Carlsquare
18 jan 2023
Carlsquare weekly market letter: The Swedish-German love affair in M&A
Equity Research
Carlsquare
11 jan 2023
Carlsquare weekly market letter: The VC market is bad, but not too bad!
Equity Research
Carlsquare
21 dec 2022
Carlsquare weekly market letter: The Swedish property market is under fire! Time to buy?
Equity Research
Carlsquare
14 dec 2022
Carlsquare weekly market letter: It is a buyers’ market, again!
Equity Research
Carlsquare
07 dec 2022
Carlsquare weekly market letter: Will Santa Claus deliver an IT rally for Christmas?
Equity Research
Carlsquare
30 nov 2022
Carlsquare weekly market letter: The market is at a vulnerable breakpoint ahead of new data
Equity Research
Carlsquare
23 nov 2022
Carlsquare weekly market letter: Will the consumers raise again?
Equity Research
Carlsquare
16 nov 2022
Carlsquare weekly market letter: It’s always darkest before dawn
Equity Research
Carlsquare
09 nov 2022
Carlsquare weekly market letter: Stock market at a breakpoint with energy and gold in focus
Equity Research
Carlsquare
02 nov 2022
Carlsquare weekly market letter: When will Fed change the inflation target => stimulating the stock market?
Equity Research
Carlsquare
26 okt 2022
Carlsquare weekly market letter: Can the upturn in the market, give some energy back to the IPO market?
Equity Research
Carlsquare
19 okt 2022
Carlsquare weekly market letter: Bull trap in the making?
Equity Research
Carlsquare
11 okt 2022
Carlsquare weekly letter: Is 5 the new wholly number, or do we need to go to 6?
Equity Research
Carlsquare
28 sep 2021
Carlsquare Weekly Letter: Focus on oil ahead of possible energy crisis
Macro and markets
Carlsquare
06 jul 2021
Anders Elgemyr: “We are living in an era of debt, and I do not see an end to it yet”
I Medier
28 apr 2021
Alphabet till nya höjder i efterhandeln. Fokus på Fed
Macro and markets
12 nov 2018
Anders Elgemyr: "It is hard to calculate an appropriate risk premium today"
I Medier
1
2
3
4
5